logo
Buzzy AI health startup Superpower is making another acquisition to power its food-as-medicine push

Buzzy AI health startup Superpower is making another acquisition to power its food-as-medicine push

Consumers increasingly want to take control of their health — including by taking control of what they eat. Buzzy AI startup Superpower just made its second acquisition of the year to capitalize on that interest.
Superpower is building a health AI "super app" that combines biannual lab tests with users' health histories to create personalized lifestyle recommendations. The startup announced $30 million in Series A funding, led by Forerunner, just last month.
Now, Superpower is buying at-home lab testing company Base, Business Insider has learned exclusively.
Base, started by former Amazon engineer Lola Priego, provides at-home blood and saliva tests to help consumers improve habits like their sleep and diet with personalized lifestyle recommendations.
It was Base's diet analysis business that sold Superpower on the deal. Superpower CEO Jacob Peters told BI that the startup bought Base primarily for its wealth of nutritional data, which he said "would save us a lot of clinical R&D" as Superpower digs deeper into food-as-medicine care.
Terms of the deal were not disclosed. Priego launched Base in 2019, and the company last raised a $3.4 million seed round in 2021 led by Female Founders Fund.
Superpower is far from the only player interested in the nutrition market. Investors are pouring hundreds of millions of dollars into nutrition care startups like Nourish and Fay Nutrition, while movements like Robert F. Kennedy Jr.'s " Make America Healthy Again" are taking hold.
Those trends, too, are picking up steam with the explosion of weight-loss drugs like Ozempic and a growing consumer fascination with longevity, as some look to hack their health and extend their lifespans.
Superpower hits on that longevity care demand, with scores provided on its app measuring users' "biological age" and overall health. The startup even hired its own "chief longevity officer" in September.
Still, Peters said Superpower isn't a longevity startup, adding that he thinks most consumers simply want to get a better hold on their health — "If you superpower your health, you superpower your life."
Superpower is making M&A central to its strategy, an unusual approach for an early-stage startup. Base is its second acquisition of the year; Superpower bought women's health startup Feminade in January.
Peters said he expects to see more consolidation across digital health to combine point solutions tackling small slices of the market. And Superpower itself wants to connect a broad range of offerings into its app so patients can get all of their health needs met in one place.
"This probably won't be our last M&A," Peters laughed.
Reimagining concierge care with AI
Peters launched Superpower in 2023 alongside cofounders Max Marchione and Kevin Unkrich, CTO, born from their personal experiences with a broken healthcare system. Peters, for one, was diagnosed with the autoimmune disorder Crohn's disease a few years ago and spent four months in the hospital, undergoing multiple surgeries and racking up seven-figure bills.
"It was a big light bulb moment for me: as a person with health challenges, no one's really coming to save you," he said.
He and the Superpower team set out to create an AI-powered experience inspired by concierge medicine, which typically offers more attentive healthcare at a higher price tag, and making that style of care more widely accessible with technology. Its approach has attracted investors from Susa Ventures to Cameron and Tyler Winklevoss.
Superpower's members take biannual lab tests, either at home or at one of Superpower's partner labs, to assess more than 100 blood biomarkers. The Superpower app then pulls in user data from patient medical records, the lab tests, and wearables, and surfaces AI-driven insights based on that data to help its members optimize their health across their nutrition, sleep, and hormones.
Superpower's AI-generated action plans are reviewed by human care teams behind the scenes. Users can message their care teams to get further combined guidance from those human providers and AI.
Many consumer health startups launch to focus on one or a few problems, as Ro and Hims and Hers did with conditions like erectile dysfunction and hair loss. Superpower wants to take a different approach, aiming to be comprehensive from day one, so the startup can be known for its platform rather than for any single offering, Peters said.
That ambition comes with a cost: Superpower's memberships run $500 a year. While lower than what most Americans spend on healthcare in a year, that price point could put the app out of reach for many consumers.
Peters said the Superpower team is thinking hard about how to make its services available to the largest group possible. Superpower launched to sell directly to consumers, but in the future, Peters said the startup may consider contracting with employers to cover the costs of its memberships for employees.
"We want to build a platform that makes it easy to get the world's best healthcare to everyone at very low and accessible costs. That's the north star for us, to put a healthcare super app and AI doctor on everyone's phone," he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone
California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone

Yahoo

time32 minutes ago

  • Yahoo

California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone

California and three other states petitioned the U.S. Food and Drug Administration Thursday to ease its new restrictions on the abortion pill mifepristone, citing the drug's proven safety record and arguing the new limits are unnecessary. "The medication is a lifeline for millions of women who need access to time-sensitive, critical healthcare — especially low-income women and those who live in rural and underserved areas," said California Atty. Gen. Rob Bonta, who filed the petition alongside the attorneys general of Massachusetts, New York and New Jersey. The petition cites Senate testimony by Health and Human Services Secretary Robert F. Kennedy Jr. last month, in which Kennedy said he had ordered FDA administrator Martin Makary to conduct a "complete review" of mifepristone and its labeling requirements. The drug, which can be received by mail, has been on the U.S. market for 25 years and taken safely by millions of Americans, according to experts. It is the most common method of terminating a pregnancy in the U.S., with its use surging after the Supreme Court overturned Roe vs. Wade in 2022. The Supreme Court upheld access to the drug for early pregnancies under previous FDA regulations last year, but it has remained a target of anti-abortion conservatives. The Trump administration has given Kennedy broad rein to shake up American medicine under his "Make America Healthy Again" banner, and Kennedy has swiftly rankled medical experts by using dubious science — and even fake citations — to question vaccine regimens and research and other longstanding public health measures. Read more: Hiltzik: MAHA report's misrepresentations will harm public health and hit consumers' pocketbooks At the Senate hearing, Kennedy cited "new data" from a flawed report pushed by anti-abortion groups — and not published in any peer-reviewed journal — to question the safety of mifepristone, calling the report "alarming." "Clearly, it indicates that, at very least, the label should be changed," Kennedy said. Sen. Josh Hawley (R-Mo.) on Monday posted a letter from Makary to X, in which Makary wrote that he was "committed to conducting a review of mifepristone" alongside "the professional career scientists" at the FDA. Makary said he could not provide additional information given ongoing litigation around the drug. The states, in their 54-page petition, wrote that "no new scientific data has emerged since the FDA's last regulatory actions that would alter the conclusion that mifepristone remains exceptionally safe and effective," and that studies "that have frequently been cited to undermine mifepristone's extensive safety record have been widely criticized, retracted, or both." Democrats have derided Kennedy's efforts to reclassify mifepristone as politically motivated and baseless. "This is yet another attack on women's reproductive freedom and scientifically-reviewed health care," Gov. Gavin Newsom said the day after Kennedy's Senate testimony. "California will continue to protect every person's right to make their own medical decisions and help ensure that Mifepristone is available to those who need it." Bonta said Thursday that mifepristone's placement under the FDA's Risk Evaluation and Mitigation Strategy program for drugs with known, serious side effects — or REMS — was "medically unjustified," unduly burdened patient access and placed "undue strain on the nation's entire health system." He said mifepristone "allows people to get reproductive care as early as possible when it is safest, least expensive, and least invasive," is "so safe that it presents lower risks of serious complications than taking Tylenol," and that its long safety record "is backed by science and cannot be erased at the whim of the Trump Administration." Read more: Q&A: The FDA says the abortion pill mifepristone is safe. Here's the evidence The FDA has previously said that fewer than 0.5% of women who take the drug experience 'serious adverse reactions,' and deaths are exceedingly rare. The REMS program requires prescribers to add their names to national and local abortion provider lists, which can be a deterrent for doctors given safety threats, and pharmacies to comply with complex tracking, shipping and reporting requirements, which can be a deterrent to carrying the drug, Bonta said. It also requires patients to sign forms in which they attest to wanting to "end [their] pregnancy," which Bonta said can be a deterrent for women using the drug after a miscarriage — one of its common uses — or for those in states pursuing criminal penalties for women seeking certain abortion care. Under federal law, REMS requirements must address a specific risk posed by a drug and cannot be "unduly burdensome" on patients, and the new application to mifepristone "fails to meet that standard," Bonta said. The states' petition is not a lawsuit, but a regulatory request for the FDA to reverse course, the states said. If the FDA will not do so nationwide, the four petitioning states asked that it "exercise its discretion to not enforce the requirements" in their states, which Bonta's office said already have "robust state laws that ensure safe prescribing, rigorous informed consent, and professional accountability." Get the L.A. Times Politics newsletter. Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond, in your inbox twice per week. This story originally appeared in Los Angeles Times.

Coinbase Unlocks DeFi Opportunities for XRP and Dogecoin Holders on Base
Coinbase Unlocks DeFi Opportunities for XRP and Dogecoin Holders on Base

Yahoo

time37 minutes ago

  • Yahoo

Coinbase Unlocks DeFi Opportunities for XRP and Dogecoin Holders on Base

Crypto traders holding XRP XRP and dogecoin DOGE can now tap into yield-generating decentralized finance (DeFi) opportunities on Base, the layer-2 blockchain from digital assets exchange Coinbase (COIN). On Wednesday, the Nasdaq-listed exchange said the wrapped versions of the two tokens, called cbXRP and cbDOGE, were live on Base. These wrapped tokens are backed 1:1 by native coins, meaning that for all cbXRP and cbDOGE in circulation, there is an equivalent amount of XRP or dogecoin held in a secure custody solution by Coinbase. Wrapped tokens represent the original assets in environments where they are otherwise unavailable, offering compatibility with Base's protocol and DeFi applications. This facilitates interoperability, allowing for the seamless transfer of coins within the ecosystem while allowing holders to tap into DeFi and generate additional returns on top of their spot market holdings. The wrapped version of XRP has achieved a market cap of over $5 million within the first 24 hours, according to data source BaseScan. Wrapped DOGE's market cap is fast nearing the $2 million mark. XRP is a payments-focused cryptocurrency used by Ripple to facilitate cross-border transactions and has a market cap of $128.8 billion, making it the fourth-largest cryptocurrency. Dogecoin, with a market value of $28.2 billion, is the world's leading meme token by market value, CoinDesk data show. Coinbase debuted a wrapped version of bitcoin BTC, the largest cryptocurrency, on Base in September last year. That has reached a market cap of over $4.7 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

MAHA, social media further complicating parenthood
MAHA, social media further complicating parenthood

Yahoo

timean hour ago

  • Yahoo

MAHA, social media further complicating parenthood

(NewsNation) — New parents have always sought advice about whether to sleep train or use formula, but the 'Make America Healthy Again' movement has raised even more questions. Initiatives backed by Robert F. Kennedy Jr. have filled social media feeds with polarizing topics, including questions about raw milk, unmedicated childbirth, ultraprocessed foods and vaccinations. A national poll by C.S. Mott Children's Hospital found four out of five parents with young children — from newborn to 4 years old — use social media to discuss their concerns about a range of parenting topics. 'Agroterrorism' fungus could harm US crops, livestock: Scientist Holistic pediatrician Dr. Ana Maria Temple told NewsNation that parents can honor their own values and make sound choices — if they're able to filter out the filler they find online. Rather than following thousands of Facebook, Instagram and TikTok pages and driving 'yourself insane,' Temple recommends going 'back to finding a provider with clinical expertise that can sit and work with you.' But the divisiveness on these topics goes beyond social media — it's happening on the soccer field over post-game snacks, at kids' parties over the birthday treats served and even at schools over the cleaning products used in the classroom. Doctor: Texas junk food bill a step in the right direction Temple said to keep an open mind and avoid self-criticism when absorbing all of these different suggestions and views, both online and in person. One of the MAHA movement's most prominent thought leaders, Moms Across America founder Zen Honeycutt, suggested looking for tried-and-true options from other parents. 'Our moms have tried dozens of different ways to recover our children from their health issues, and they're sharing the ones that work the best,' Honeycutt said. 'And doesn't mean that it'll work for your child, but it's something that our mothers have tried.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store